Renaissance Technologies
DWTX

Renaissance Technologies’s Dogwood Therapeutics DWTX Stock Holding History

Renaissance Technologies’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-660
Closed -$2.81K – 3977
2024
Q3 		$2.81K Buy
+660
New +$3.42K ﹤0.01% 3482
2024
Q1 		– Sell
-8,268
Closed -$119K – 4152
2023
Q4 		$119K Buy
8,268
+7,708
+1,376% +$130K ﹤0.01% 3260
2023
Q3 		$13K Sell
560
-1,296
-70% -$45.1K ﹤0.01% 3570
2023
Q2 		$64K Sell
1,856
-80
-4% -$2.28K ﹤0.01% 3569
2023
Q1 		$18K Sell
1,936
-7,480
-79% -$59.5K ﹤0.01% 3841
2022
Q4 		$56K Buy
9,416
+2,352
+33% +$17.7K ﹤0.01% 3779
2022
Q3 		$67K Buy
+7,064
New +$995K ﹤0.01% 3694

Other funds holding DWTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Renaissance Technologies's DWTX Position: Q4 2024 in Review

Renaissance Technologies sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 660 shares — an estimated $2.81K sold.

Renaissance Technologies first reported a position in DWTX in Q3 2022 and held it in 7 quarters. The position peaked at $119K in Q4 2023. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

  • Renaissance Technologies reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 660 Dogwood Therapeutics shares in Q4 2024, an estimated $2.81K.
  • Renaissance Technologies first reported a position in Dogwood Therapeutics in Q3 2022 and held it in 7 quarters.
  • Renaissance Technologies's Dogwood Therapeutics position peaked at $119K in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.